Suchergebnisse - "Salazar, Ramon"

PubPharm (302)

31

MmCMS: Mouse models’ Consensus Molecular Subtypes of colorectal cancer

enthalten in: bioRxiv.org | 2022

von Amirkhah, R. | Gilroy, K. | Malla, S. | +17

32

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis

enthalten in: Nature communications | 2022

von Solé, L. | Lobo-Jarne, T. | Álvarez-Villanueva, D. | +24

33

Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors

enthalten in: Nature cancer | 2022

von Herpers, B. | Eppink, B. | James, M. | +36

CommentIn: Nat Cancer. 2022 Apr;3(4):379-380. - PMID 35469016

34

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

enthalten in: Journal for immunotherapy of cancer | 2022

von Garcia-Carbonero, R. | Bazan-Peregrino, M. | Gil-Martín, M. | +21

35

Learning in times of stress : Lessons from COVID-19 that will last throughout this century

enthalten in: European journal of internal medicine | 2022

von Jiménez-Fonseca, P. | Salazar, R. | Valentí, V. | +2

36

Streptozotocin, 1982-2022 : Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors

enthalten in: Neuroendocrinology | 2022

von Capdevila, J. | Ducreux, M. | García Carbonero, R. | +7

37

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78

38

Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit

enthalten in: Cancer investigation | 2022

von Valentí, V. | Jiménez-Fonseca, P. | Msaouel, P. | +2

39

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

40

The 40S-LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity

enthalten in: Science advances | 2021

von Fuentes, P. | Pelletier, J. | Martinez-Herráez, C. | +9